Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide

Critical Care Medicine

Volumn 26, Issue 12, 1998, Pages 2021-2028

  Pedoto, Alessia ^a   Tassiopoulos, Apostolos K ^b   Oler, Albert ^b   McGraw, Daniel J ^b   Hoffmann, Stephen P ^b   Camporesi, Enrico M ^a   Hakim, Tawfic S ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Escherichia coli lipopolysaccharide; Lung damage; Nitric oxide synthase inhibitors; Nitric oxide, exhaled; Nitric oxide, inhaled; Septic shock; Systemic hypotension

Indexed keywords

AMINOGUANIDINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BLOOD PH; CONTROLLED STUDY; HYPOTENSION; INHALATIONAL DRUG ADMINISTRATION; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

ADMINISTRATION, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI INFECTIONS; FREE RADICAL SCAVENGERS; GUANIDINES; HEMODYNAMIC PROCESSES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TIME FACTORS;

EID: 0032445945     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199812000-00034     Document Type: Article

References (57)

1. Clancy RM, Abramson S: Nitric oxide: A novel mediator of inflammation. Soc Exp Biol Med 1995; 210:93-101
2. Parrillo JE: Pathogenetic mechanisms of septic shock. New Engl J Med 1993; 328:1471-1477
3. Cobb JP, Danner RL: Nitric oxide and septic shock. JAMA 1996; 275: 1192-1196
4. Lorente JA, Landin L, De Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287-1295
5. Julou-Schaeffer G, Gray GA, Fleming I, et al: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038-H1043
6. Demling RH, Smith M, Gunther R, et al: Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol 1981; 240:H348-H353
7. Bone R: A new therapy for the adult respiratory distress syndrome. New Engl J Med 1993; 328:431-432
8. Weitzberg E, Rudehill A, Lundberg JM: Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 1993; 233:85-94
9. Brigham K, Meyrick B: Endotoxin and lung injury. Am Rev Respir Dis 1986; 133:913-927
10. Parrillo JE: Septic shock in humans: Advances in understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227-242
11. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in human with septic shock. Cardiovasc Res 1994; 28:34-39
12. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
13. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182:591-595
14. G-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med 1995; 23:1018-1024
15. Robertson FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149-156
16. Wu CC, Chen SJ, Szabó C, et al: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995; 114: 1666-1672
17. Teale DM, Atkinson AM: L-Canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol 1994; 271:87-92
18. Szabó C, Mitchell JA, Thiemermann C, et al: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108:786-792
19. Griffiths MJD, Messent M, Mac Allister RJ, et al: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110:963-968
20. ω-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxemia in the rat. Eur J Pharmacol 1996; 300: 99-104
21. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 1991; 338:1555-1557
22. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20: S132-S134
23. Spath JA, Sloane PJ, Gee MH, et al: Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin. J Appl Physiol 1994; 76:361-369
24. Gustafsson LE: Experimental studies on nitric oxide. Scand J Work Environ Health 1993; 19:44-49
25. Roissant R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med 1993; 328:399-405
26. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide: A selective pulmonary vasodilator reversing pulmonary vasoconstriction. Circulation 1991; 83:2038-2047
27. Zapol WM, Falke KJ, Hurford WE, et al: Inhaling nitric oxide: A selective pulmonary vasodilator and bronchodilator. Chest 1994; 105:878-918
28. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
29. Tracey WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Therap 1995; 272:1011-1015
30. Booke M, Meyer J, Lingnau W, et al: Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horiz 1995; 3:123-138
31. Bigatello LM, Hurford WE, Kacmarek RM, et al: The hemodynamic and respiratory response of ARDS patients to prolonged nitric oxide inhalation. Abstr. Am Rev Respir Dis 1993; 147:A718
32. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
33. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock - A review of laboratory models and a proposal. J Surg Res 1980; 29:189-201
34. Danner RL, Elin LJ, Hosseini JM, et al: Endotoxemia in human septic shock. Chest 1991; 99:169-175
35. Gaston B, Drazen JM, Loscalzo J, et al: The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551
36. Hibbs JB, Taintor RR, Vavrin Z, et al: Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94
37. Hibbs JB, Taintor RR, Vavrin Z: Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 1984; 123:716-723
38. Stadler J, Billiar TR, Curran RD, et al: Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991; 260:C910-C916
39. Clancy RM, Levartovsky D, Leszczynska-Piziac J, et al: Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: Evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci U S A 1994; 91:3680-3684
40. Miles PR, Bowman L, Huffman L: Nitric oxide alters metabolism in isolated alveolar type II cells. Am J Physiol 1996; 271:L23-L30
41. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258: 1898-1902
42. Kelley J: Cytokines of the lung. Am Rev Respir Dis 1990; 141:765-788
43. Stewart TE, Valenza F, Ribeiro SP, et al: Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995; 151:713-718
44. Szabó C, Wu CC, Mitchell JA: Platelet activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993; 73:991-999
45. Van der Berg C, Van Amsterdam JGC, Bisschop A, et al: Septic shock: No correlation between plasma levels of nitric oxide metabolites and hypotension or lethality. Eur J Pharmacol 1994; 270:379-382
46. Biegansky T, Kusche J, Lorenz W, et al: Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochem Biophys Acta 1983; 756: 196-203
47. Seiler N, Bolenius FN, Knodgen B: The influence of catabolic reactions on polyamine excretion. Biochem J 1985; 225:219-226
48. Ou P, Wolff SP: Aminoguanidine: A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 1993; 46:1139-1144
49. Park JH, Chang SH, Lee KM, et al: Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 1996; 171:340-345
50. G-Nitro-L-Arginine pharmacokinetics in rats after a single intravascular and oral dose: An appearance of secondary concentration time peaks. Drug Metab Dispos 1993; 21:962-964
51. G-nitroarginine (NOARG) inhibits endothelium-dependent vasodilation in the rabbit aorta and perfused rat mesentery. Abstr. Br J Pharmacol 1989; 98:905P
52. Rees DD, Palmer RM, Schulz R, et al: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752
53. Warren JB, Higenbottam T: Caution with use of inhaled nitric oxide. Lancet 1996; 348:629-630
54. Offner PJ, Ogura H, Jordan BS, et al: Cardiopulmonary effects of combined nitric oxide inhibition and inhaled nitric oxide in porcine endotoxin shock. J Trauma 1996; 41:641-646
55. Klemm P, Thiemermann C, Winklmaier G, et al: Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol 1995; 114:363-368
56. Atwood RP, Kass EH: Relationship of body temperature to the lethal action of bacterial endotoxin. J Clin Invest 1964; 43(Suppl2):151-159
57. Blair E, Henning G, Hornick R, et al: Hypothermia in bacterial shock. Arch Surg 1964; 89:619-629